Abstract. Chronic inflammation is associated with an infiltration of mononuclear cells, fibroblast proliferation, and elevated levels of prostaglandin (PG) E2. Mononuclear cell conditioned factor (MNCF) medium (5%) stimulated a 100-fold increase in basal human dermal fibroblast PGE2 release over 48 h as compared with fibroblasts that were incubated with control medium (conditioned medium prepared without cells). The MNCF-induced PGE2 production was suppressed by protein synthesis inhibitors. Fibroblasts pretreated with control medium released PGE2 only modestly in response to 1 nM bradykinin for 1 h (basal, 50±7 pg PGE2/,g protein; stimulated, 104±12 pg PGE2flsg protein), whereas cells that had been pretreated with MNCF showed a greatly facilitated bradykinin-induced release of PGE2. (basal, 297±59 pg PGE2/,g protein; stimulated, 866±85 pg PGE2/Ag protein). The exaggerated agonist response is not specific for bradykinin because plateletderived growth factor elicits a similar response. Exogenous arachidonic acid conversion to PGE2 was also facilitated (two-to threefold) by MNCF pretreatment as compared with control. Both the enhanced agoniststimulated and exogenous arachidonic acid-induced PGE2 release from the MNCF pretreated cells were inhibited by actinomyin D or cycloheximide. A kinetic study of microsomal cyclooxygenase prepared from fibroblasts pretreated with MNCF showed a threefold increase in the maximum velocity (Vmax) but the same Michaelis constant (Kin) as control-treated cells. This augmented arachidonic acid metabolism and subsequent enhanced PGE2 production may play an important role
Introduction
Chronic tissue inflammation is generally associated with an infiltration of mononuclear cells and a fibrogenesis. Monocytes, when stimulated, release a whole spectrum of products, including arachidonic acid (AA)' metabolites (1) , complement components (2) , and monokines (3) , which elicit a large number of responses on local vasculature, immune processes, and various target cell functions. Endogenous mediators of inflammation, such as bradykinin and prostaglandins (PG), are derived from the injured tissue. Bradykinin is formed by cleavage of kininogen by kallikrein (4) , and during the inflammatory reaction acts as a vasodilator (5) and increases vascular permeability (6) , thereby contributing to the edema. Bradykinin also elicits PG release from various intact organ systems (7) as well as different cell types such as fibroblasts (8) and endothelial cells (9) . Chronic inflammation has been associated with elevated levels of PGE2 at the site of injury. PGE2 is a vasodilator (10) , enhances vascular permeability (11) , and plays a role in the regulation of the immune response by modulating T lymphocyte proliferation, macrophage cytotoxicity, and lymphokine production (12).
Macrophages seem to actively modulate fibroblast proliferation and PG production (13) . Human peripheral blood mononuclear cells in vitro release a variety of factors over a 72-h period into the culture medium. The supernatant medium from these cultures contains a factor that results in a marked (50-200-fold) stimulation of PGE2 biosynthesis from dermal fibroblasts (13) , gingival fibroblasts (14) , synovial cells (15) , and lung fibroblasts (16) . In some models, such as pulmonary fibrosis, the monocyte-conditioned medium suppresses fibroblast proliferation by stimulation of PGE2 production (16) .
The rabbit hydronephrotic kidney (HNK), a model of renal injury, exhibits histological evidence of a macrophage invasion and fibroblast proliferation, and is associated with a greatly exaggerated renal AA metabolism in response to stimulation with bradykinin (17) . An in vitro cell culture derived from HNK cortical explants contained macrophages and fibroblasts and elicited a profound PGE2 synthesis in response to bradykinin and exogenous AA (18) . Since mononuclear-cell conditioned medium stimulates basal fibroblast PGE2 production, we reasoned that the conditioned medium might also alter agonist-stimulated fibroblast PGE2 production. This paper addresses the mechanism by which mononuclear cell factor alters both basal-and agonist-stimulated fibroblast AA metabolism.
Methods
Cell cultures. Human dermal fibroblasts were obtained from the American Type Cell Culture Collection, Rockville, MD (CRL 1445).
Cells were maintained in 150 cm2 tissue culture flasks (Coming Glassworks, Coming, NY) in minimal essential medium alpha (Basic Cancer Center, Washington University, St. Louis, MO), 15 mM Hepes buffer, L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin (100 sg/ml) ( were pretreated with either control or MNCF medium for 48 h. The cells were then washed, scraped from the flask, and centrifuged in aMO for 10 min at 1,000 rpm. The cells were resuspended in I ml of 50 mM Tris buffer (pH 7.8) containing 1% bovine serum albumin and 10 mM EGTA. The suspension was sonicated for 30 s in a Cell Disruptor 350 (Sonifier) at pulsed 40% duty cycle, three output control. Microscopic examination revealed that the cells were completely broken apart. The disrupted cells were centrifuged at 8,000 g for 15 min, and the resulting supernatant was centrifuged at 100,000 g for 60 min. The pellets obtained were washed with 50 mM Tris buffer (pH 7.8) and I mM EGTA. The pellet was then resuspended in a glass homogenizer with 500 til of the 50 mM Tris buffer (pH 7.8), 1 RIA ofPGE2. PGE2 was analyzed with rabbit antiserum as previously described (20). The cross-reactivity at 50% displacement of other PGs with the antiserum is as follows: 6-keto-PGFa, 0.39%; PGF2a, 0.04%; TxB2, 0.009%.
Results
Effect ofMNCF on basalfibroblast PGE2 accumulation. When fibroblasts (104 cells/well) were incubated with 5% MNCF (determined to be an optimal dose; data not shown) or 5% control medium for 48 h (Table I) (Fig. 1 B) .
Since this altered peptide-induced fibroblast PGE2 release was quite dramatic, we explored the mechanism by which this might occur. Exogenous AA at varying doses was incubated with cells ( Fig. 2) Effect of MNCF on fibroblast cyclooxygenase activity. Microsomes were prepared from fibroblasts (5 X 106 cells/flask) cultured for 48 h with 5% control medium or 5% MNCF as described in Methods.
Varying concentrations of AA were incubated with 40-50 ,sg of microsomal protein for 10 min at 370C. In some incubations, microsomes were preincubated with indomethacin before incubation with AA, which completely abolished the response.
removed and various agonists were added for 1 h (Fig. 3) . (18) . Passaged HNK cultures, which only contained fibroblasts, produced much less PGE2 in response to bradykinin and AA, whereas CLK fibroblast responses remained unchanged with passag;. Therefore, the mechanism invoked here is that macrophage in the primary HNK co-culture system can modulate the fibroblast cyclooxygenase and bradykinin response, consistent with our current data. PGE2 is thought to have many functions at a site of inflammation. This study demonstrates the possibility of an amplification scheme to greatly enhance local concentrations of PGE2. Thus, not only mononuclear cells can chronically stimulate fibroblast PGE2, but agonists such as bradykinin, present at the inflammation, can also have a profound impact on fibroblast PGE2 release.
